Clinical trial
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable…
NCT00272909 · Daiichi Sankyo, Industry · Terminated
Key facts
| NCT number | NCT00272909 |
|---|---|
| Title | Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) |
| Official title | A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | piclozotan low dose, placebo, piclozotan high dose |
| Enrollment | 43 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Jan 9, 2006 |
| Last update posted | Oct 20, 2015 |
| Countries | Belgium, Germany, Israel, Poland, South Africa, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: